Skip to main content
OpenTrials
Completed

NCT Number: NCT00081965

Acupuncture in Treating Hot Flashes in Women With Breast Cancer

RATIONALE: Acupuncture may help relieve hot flashes in women with breast cancer. It is not yet known whether acupuncture is more effective than a placebo in treating hot flashes in women with breast cancer

PURPOSE: This randomized clinical trial is studying acupuncture to see how well it works compared to a placebo in treating hot flashes in women with breast cancer.

Completed

Looking for future studies?

Notify Me

Key information

About this study

OBJECTIVES:

Primary

  • Determine whether acupuncture, compared to placebo, reduces the incidence of hot flashes in women with breast cancer.

Secondary

  • Determine the long-term effects of acupuncture on hot flashes.

OUTLINE: This a randomized, placebo-controlled, multicenter study. Patients are stratified according to concurrent treatment with selective estrogen receptor modulators, gonadotropin-releasing hormone analogs, or aromatase inhibitors (yes vs no), concurrent use of hot flash medication or selective serotonin reuptake inhibitors (SSRIs) (yes vs no), baseline hot flash frequency (> 7 per day), and menopausal status at diagnosis (premenopausal vs postmenopausal). Patients are randomized to 1 of 2 treatment arms.

  • Arm I (treatment): Patients receive 8 acupuncture treatments over 4 weeks.
  • Arm II (control): Patients receive 8 placebo acupuncture treatments over 4 weeks. Beginning at week 7, patients are offered 8 true acupuncture treatments over 4 weeks.

Patients in both arms complete a "hot flash" diary for 1 week before treatment and then periodically during and after treatment.

After completion of study treatment, patients are followed periodically.

PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Diagnosis of breast cancer (including in situ disease)
  • Must be receiving treatment for breast cancer at Memorial Sloan Kettering Cancer Center (MSKCC) or its regional site (Commack)
  • Has an average of 3 or more hot flashes a day during 1 week of baseline diary recording
  • Hormone receptor status not specified

PATIENT CHARACTERISTICS:

  • Female
  • Pre- or postmenopausal
  • Karnofsky performance status 70-100%
  • Ambulatory
  • No skin infection

PRIOR CONCURRENT THERAPY:

  • More than 3 weeks since prior and no concurrent treatment with any of the following during the 6 week evaluation period of the trial:
  • Surgery
  • Initiation of a new chemotherapy regimen
  • Initiation of immunotherapy
  • Initiation of radiotherapy
  • Initiation or cessation of hormonal therapy
  • More than 6 weeks since prior acupuncture treatment (6 months for acupuncture specifically for the treatment of hot flashes)
  • No concurrent pharmacological treatment for hot flashes unless dose has been stable for 4 weeks
  • No concurrent selective serotonin reuptake inhibitors (SSRIs) unless dose has been stable for 4 weeks

Treatment and study plan

acupuncture therapy

Procedure

hot flashes attenuation

Procedure

management of therapy complications

Procedure

Primary outcomes

  1. Frequency and severity of hot flashes, as measured by a hot flash diary

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial

Important dates

Primary completion
2007
Study completion
2007
First posted
Apr 28, 2004
Registry last updated
Dec 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.